ConquerX

About ConquerX

ConquerX's Metachip technology represents a game-changing approach to cancer diagnostics and screening by leveraging a new class of biomarkers - microRNAs - to earlier detect up to eighteen types of cancer in one accurate, cost-effective blood test.
YEAR FOUNDED:
2016
LEADERSHIP:
Co-Founder and CEO: Deborah Zanforlin, M.Sc.
Co-Founder and CSO: Jorge Sánchez López
Co-Founder and CTO: Jakub Chudik
Co-Founderand COO: To Nhu Huynh, MPH
Advisor: Isaac Stoner
TECHNOLOGY:
Please click here for ConquerX' technology.